Literature DB >> 6498674

[Immunologic aspects of 2 modes of prevention of urinary tract infection in children with trimethoprim-sulfamethoxazole].

J Labbé.   

Abstract

Two types of prophylaxis of urinary tract infection with trimethoprim-sulfamethoxazole (TMP-SMZ) were studied in 72 children with recurrent urinary tract infections or vesicoureteral reflux or both. Daily prophylaxis only was used in 36 children and thrice-weekly prophylaxis only in 25 others, and 11 children received successively both types of prophylaxis. The same dosage was used in all cases: 2 mg/kg of TMP and 10 mg/kg of SMZ, given at bedtime. With daily prophylaxis the infection rate over 556 patient-months was 5.4 cases per 1000 patient-months, compared with 285.4 cases in the year before prophylaxis; side effects were noted in 11% of the patients during treatment. With thrice-weekly prophylaxis the infection rate over 381 patient-months was 15.7 cases per 1000 patient-months, compared with 313.6 cases in the year before prophylaxis; only 3% of the patients receiving this treatment had a side effect that was possibly drug-related. These results indicate that effective prophylaxis of urinary tract infection in children can be obtained with these two types of treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498674      PMCID: PMC1483682     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  17 in total

1.  A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women.

Authors:  G K Harding; A R Ronald
Journal:  N Engl J Med       Date:  1974-09-19       Impact factor: 91.245

2.  Trimethoprim-sulfamethoxazole in recurrent urinary tract infection in children.

Authors:  P A Forbes; K N Drummond
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

3.  Urologic aspects of recurrent urinary tract infection in children.

Authors:  F D Stephens
Journal:  J Pediatr       Date:  1972-05       Impact factor: 4.406

4.  Urinary infection prophylaxis in women.

Authors:  A R Ronald; G K Harding
Journal:  Ann Intern Med       Date:  1981-02       Impact factor: 25.391

5.  Trimethoprim-sulfamethoxazole.

Authors:  W T Hughes
Journal:  Pediatr Clin North Am       Date:  1983-02       Impact factor: 3.278

Review 6.  Vesicoureteral reflux: a surgeon's perspective.

Authors:  R M Ehrlich
Journal:  Pediatr Clin North Am       Date:  1982-08       Impact factor: 3.278

7.  Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora.

Authors:  T A Stamey; M Condy; G Mihara
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

8.  Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection.

Authors:  J M Smellie; R N Grüneberg; I C Normand; H M Bantock
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

9.  Antimicrobial prophylaxis in children with urinary tract infection and vesicoureteral reflux.

Authors:  N H Holland; M Kazee; D Duff; J W McRoberts
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

10.  Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial.

Authors:  W E Stamm; G W Counts; K F Wagner; D Martin; D Gregory; M McKevitt; M Turck; K K Holmes
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.